Operating Lease, Payments in USD of C4 Therapeutics, Inc. from Q1 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
C4 Therapeutics, Inc. quarterly Operating Lease, Payments history and change rate from Q1 2022 to Q1 2025.
  • C4 Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $2.25M, a 2.98% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)

C4 Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $2.25M +$65K +2.98% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-07
Q1 2024 $2.18M +$64K +3.02% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-07
Q1 2023 $2.12M +$1.21M +133% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $908K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.